- 5th Annual Immuno-Oncology 360° conference in
New York ,February 6-8, 2019
Presenter:Maria Fardis , Ph.D., President and Chief Executive Officer
Session: Next Generation Cell Therapy Plenary
Title: Advancing the Development of Tumor Infiltrating Lymphocytes for Solid Tumors
Location:Crowne Plaza Times Square
Date/Time:February 8 at11:10 a.m. EST
- Guggenheim Healthcare Talks Idea Forum Oncology Day in
New York onFebruary 14, 2019
Date/Time:Thursday, February 14, 2019 at3:00 p.m. EST
Location:The St. Regis New York Hotel
Webcast: A live and archived audio webcast of the presentation will be available in the Investors section at www.iovance.com.
- ASCO-SITC Clinical Immuno-Oncology Symposium in
San Francisco ,February 28-March 2, 2019
Presenter:Amod Sarnaik , M.D. –H. Lee Moffitt Cancer Center
Poster Presentation Title: Safety and efficacy of cryopreserved autologous tumor infiltrating lymphocyte therapy (LN-144, lifileucel) in advanced metastatic melanoma patients previously treated with at least one prior systemic therapy
Abstract Number: 136
Date/Time: The poster will be presented onFriday, March 1, 2019 from11:30 a.m.-1:00 p.m. and5:30 p.m.-6:30 p.m. PST (Poster Session B, Board F1)
Location: San Francisco Marriott Marquis
About Iovance Biotherapeutics, Inc.
Investor Relations Contacts:
Solebury Trout
646-378-2972
achang@troutgroup.com
Solebury Trout
646-378-2947
crubin@troutgroup.com
Media Relations Contact:
Solebury Trout
646-378-2958
rallan@troutgroup.com